Francesco Ardito, Francesco Razionale, Andrea Campisi, Çınar Turgay, Alessandro Coppola, Simone Vani, Maria Vellone, Felice Giuliante
{"title":"Very Early Recurrence Following Liver Resection for Intrahepatic Cholangiocarcinoma: Is It Predictable by Clinical Preoperative Factors?","authors":"Francesco Ardito, Francesco Razionale, Andrea Campisi, Çınar Turgay, Alessandro Coppola, Simone Vani, Maria Vellone, Felice Giuliante","doi":"10.1111/ans.70311","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Approximately one-quarter of patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) experience very early recurrence (within 6 months after liver resection), which is associated with a poor prognosis. Identifying factors associated with very early recurrence may help optimize patient selection for surgery and avoid futile, high-risk hepatectomies. The aim of this study was to assess whether preoperative clinical factors alone can reliably predict very early recurrence following curative liver resection for ICC.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 83 patients who underwent liver resection between 2010 and 2020.</p><p><strong>Results: </strong>The 5-year overall survival (OS) rate for the entire cohort was 51.4%. Recurrence occurred in 54 patients (65.1%), with 17 (20.5%) experiencing very early recurrence. The 5-year OS for patients with very early recurrence was significantly lower than for those without it (0% vs. 48.7%, respectively; p = 0.013). Preoperative clinical prognostic factors failed to identify patients at high risk of very early recurrence, which occurred in 21% of patients classified as low risk.</p><p><strong>Conclusions: </strong>Preoperative clinical factors alone are insufficient for accurate risk stratification. Integrating clinicopathological data with molecular classifications of ICC is urgently needed to enable a more personalized oncological approach for these patients.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ANZ Journal of Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ans.70311","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Approximately one-quarter of patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) experience very early recurrence (within 6 months after liver resection), which is associated with a poor prognosis. Identifying factors associated with very early recurrence may help optimize patient selection for surgery and avoid futile, high-risk hepatectomies. The aim of this study was to assess whether preoperative clinical factors alone can reliably predict very early recurrence following curative liver resection for ICC.
Methods: A retrospective analysis was conducted on 83 patients who underwent liver resection between 2010 and 2020.
Results: The 5-year overall survival (OS) rate for the entire cohort was 51.4%. Recurrence occurred in 54 patients (65.1%), with 17 (20.5%) experiencing very early recurrence. The 5-year OS for patients with very early recurrence was significantly lower than for those without it (0% vs. 48.7%, respectively; p = 0.013). Preoperative clinical prognostic factors failed to identify patients at high risk of very early recurrence, which occurred in 21% of patients classified as low risk.
Conclusions: Preoperative clinical factors alone are insufficient for accurate risk stratification. Integrating clinicopathological data with molecular classifications of ICC is urgently needed to enable a more personalized oncological approach for these patients.
背景:大约四分之一接受肝内胆管癌(ICC)切除术的患者会经历非常早期的复发(肝切除术后6个月内),这与预后不良有关。识别与早期复发相关的因素可能有助于优化患者的手术选择,避免无效的、高风险的肝切除术。本研究的目的是评估术前临床因素是否可以可靠地预测ICC肝切除术后的早期复发。方法:对2010年至2020年83例肝切除术患者进行回顾性分析。结果:整个队列的5年总生存率(OS)为51.4%。复发54例(65.1%),早期复发17例(20.5%)。极早期复发患者的5年OS明显低于无复发患者(0% vs. 48.7%; p = 0.013)。术前临床预后因素无法识别极早期复发的高危患者,21%的低危患者出现极早期复发。结论:术前单纯的临床因素不足以进行准确的危险分层。迫切需要将临床病理数据与ICC的分子分类相结合,以便为这些患者提供更个性化的肿瘤学方法。
期刊介绍:
ANZ Journal of Surgery is published by Wiley on behalf of the Royal Australasian College of Surgeons to provide a medium for the publication of peer-reviewed original contributions related to clinical practice and/or research in all fields of surgery and related disciplines. It also provides a programme of continuing education for surgeons. All articles are peer-reviewed by at least two researchers expert in the field of the submitted paper.